BioCentury
ARTICLE | Company News

Aurora, GlaxoSmithKline deal

January 16, 2001 8:00 AM UTC

ABSC granted GSK global access to its assay technologies for ion channel discovery. The deal includes ABSC’s voltage sensor probes and first and second generation voltage ion probe reader (VIPR and VI...